Dunne M |
WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics. |
1999 |
Am. Heart J. |
pmid:10539870
|
Grayston JT |
Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis. |
1999 |
Am. Heart J. |
pmid:10539875
|
Hillis GS et al. |
Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study. |
2004 |
Am. Heart J. |
pmid:15215794
|
Gabrielli M et al. |
Azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome. |
2005 |
Am. Heart J. |
pmid:16084141
|
Schneider CA et al. |
In vivo uptake of azithromycin in human coronary plaques. |
2000 |
Am. J. Cardiol. |
pmid:11018204
|
Kuvin JT et al. |
Effect of short-term antibiotic treatment on Chlamydia pneumoniae and peripheral endothelial function. |
2003 |
Am. J. Cardiol. |
pmid:12633811
|
Hyodo E et al. |
Effect of azithromycin therapy on coronary circulation in patients with coronary artery disease. |
2004 |
Am. J. Cardiol. |
pmid:15566918
|
Lin L et al. |
A retrospective study on clinical features of and treatment methods for 77 severe cases of SARS. |
2003 |
Am. J. Chin. Med. |
pmid:14992536
|
Choi AH et al. |
Clinicocytopathologic correlation in an atypical presentation of lymphadenopathy with review of literature. |
2015 |
Am. J. Clin. Pathol. |
pmid:25873511
|
Sadatsafavi M et al. |
The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model. |
2016 |
Am. J. Epidemiol. |
pmid:27737842
|
Koukounari A et al. |
Using a nonparametric multilevel latent Markov model to evaluate diagnostics for trachoma. |
2013 |
Am. J. Epidemiol. |
pmid:23548755
|
Bertoni G et al. |
Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. |
1996 |
Am. J. Gastroenterol. |
pmid:8607489
|
Di Mario F et al. |
Azithromycin for the cure of Helicobacter pylori infection. |
1996 |
Am. J. Gastroenterol. |
pmid:8607490
|
Tursi A et al. |
The use of azithromycin in short-term low-dose triple therapies for Helicobacter pylori infection. |
1996 |
Am. J. Gastroenterol. |
pmid:8677967
|
Sullivan B et al. |
Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. |
2002 |
Am. J. Gastroenterol. |
pmid:12385435
|
Trevisani L et al. |
A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. |
1998 |
Am. J. Gastroenterol. |
pmid:9517646
|
al-Assi MT et al. |
Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth. |
1995 |
Am. J. Gastroenterol. |
pmid:7872278
|
Laine L et al. |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens. |
1999 |
Am. J. Gastroenterol. |
pmid:10201465
|
Mendu ML and Waikar SS |
Drug-drug interactions and acute kidney injury: caveat prescriptor. |
2014 |
Am. J. Kidney Dis. |
pmid:24820318
|
Hung AM and Hakim RM |
Dialysate and serum potassium in hemodialysis. |
2015 |
Am. J. Kidney Dis. |
pmid:25828570
|